EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis

被引：0
|
作者：
Shaofei Chen
Jiarui Pu
Jie Bai
Yuping Yin
Ke Wu
Jiliang Wang
Xiaoming Shuai
Jinbo Gao
Kaixiong Tao
Guobin Wang
Hang Li
机构：
[1] Union Hospital,Department of Gastrointestinal Surgery
[2] Tongji Medical College,Department of Pediatric Surgery
[3] Huazhong University of Science and Technology,undefined
[4] Union Hospital,undefined
[5] Tongji Medical College,undefined
[6] Huazhong University of Science and Technology,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 37卷
关键词：
Galectin-9; EZH2; Hepatocellular carcinoma; Proliferation; Metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis
    Ihira, Kei
    Dong, Peixin
    Xiong, Ying
    Watari, Hidemichi
    Konno, Yosuke
    Hanley, Sharon J. B.
    Noguchi, Masayuki
    Hirata, Noriyuki
    Suizu, Futoshi
    Yamada, Takahiro
    Kudo, Masataka
    Sakuragi, Noriaki
    ONCOTARGET, 2017, 8 (08) : 13509 - 13520
  • [42] HOXA11-AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR-124 expression by binding to EZH2
    Zhang, Wen-long
    Zhao, Ya-nan
    Shi, Zhang-zhen
    Gu, Gui-ying
    Cong, Dan
    Wei, Chen
    Bai, Yuan-song
    HUMAN CELL, 2019, 32 (04) : 504 - 514
  • [43] LncRNA RGMB-AS1 promotes laryngeal squamous cell carcinoma cells progression via sponging miR-22/NLRP3 axis
    Xu, Zhenxing
    Xi, Kai
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [44] HOXA11-AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR-124 expression by binding to EZH2
    Wen-long Zhang
    Ya-nan Zhao
    Zhang-zhen Shi
    Gui-ying Gu
    Dan Cong
    Chen Wei
    Yuan-song Bai
    Human Cell, 2019, 32 : 504 - 514
  • [45] Correction to: HOXA11‑AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR‑124 expression by binding to EZH2
    Wen‑long Zhang
    Ya‑nan Zhao
    Zhang‑zhen Shi
    Gui‑ying Gu
    Dan Cong
    Chen Wei
    Yuan‑song Bai
    Human Cell, 2021, 34 : 1946 - 1950
  • [46] P53 suppresses the progression of hepatocellular carcinoma via miR-15a by decreasing OGT expression and EZH2 stabilization
    You, Zhenyu
    Peng, Dandan
    Cao, Yixin
    Zhu, Yuanzhe
    Yin, Jianjun
    Zhang, Guangxing
    Peng, Xiaodong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (19) : 9168 - 9182
  • [47] Ropivacaine suppresses the progression of renal cell carcinoma through regulating the lncRNA RMRP/EZH2/CCDC65 axis
    Xiong, Yingfen
    Zheng, Xiaolan
    Deng, Huangying
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 32 (01) : 121 - 132
  • [48] Ropivacaine suppresses the progression of renal cell carcinoma through regulating the lncRNA RMRP/EZH2/CCDC65 axis
    Yingfen Xiong
    Xiaolan Zheng
    Huangying Deng
    DARU Journal of Pharmaceutical Sciences, 2024, 32 : 121 - 132
  • [49] EZH2 promotes the progression of osteosarcoma through the activation of the AKT/GSK3β pathway
    Wan, Dongdong
    Han, Xiuxin
    Zhang, Chao
    Zhang, Yan
    Ma, Yulin
    Wang, Guowen
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (11) : 1179 - 1186
  • [50] MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity
    Xu, Leibo
    Beckebaum, Susanne
    Iacob, Speranta
    Wu, Gang
    Kaiser, Gernot M.
    Radtke, Arnold
    Liu, Chao
    Kabar, Iyad
    Schmidt, Hartmut H.
    Zhang, Xiaoyong
    Lu, Mengji
    Cicinnati, Vito R.
    JOURNAL OF HEPATOLOGY, 2014, 60 (03) : 590 - 598
12345